BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 3016896)

  • 1. Psychotomimesis mediated by kappa opiate receptors.
    Pfeiffer A; Brantl V; Herz A; Emrich HM
    Science; 1986 Aug; 233(4765):774-6. PubMed ID: 3016896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
    Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
    Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action.
    Sonders MS; Keana JF; Weber E
    Trends Neurosci; 1988 Jan; 11(1):37-40. PubMed ID: 2469154
    [No Abstract]   [Full Text] [Related]  

  • 4. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats.
    Nikolarakis K; Pfeiffer A; Stalla GK; Herz A
    Brain Res; 1987 Sep; 421(1-2):373-6. PubMed ID: 2825911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid kappa-receptor agonists suppress sexual behaviors in male rough-skinned newts (Taricha granulosa).
    Deviche P; Moore FL
    Horm Behav; 1987 Sep; 21(3):371-83. PubMed ID: 2822565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH
    Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice.
    Hiramatsu M; Nabeshima T; Kameyama T
    J Pharmacobiodyn; 1986 May; 9(5):466-72. PubMed ID: 3020223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
    Panerai AE; Martini A; Sacerdote P; Mantegazza P
    Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine ("angel dust") analogs and sigma opiate benzomorphans cause cerebral arterial spasm.
    Altura BT; Quirion R; Pert CB; Altura BM
    Proc Natl Acad Sci U S A; 1983 Feb; 80(3):865-9. PubMed ID: 6298779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the selective kappa-opioid agonist MR 2034 on the guinea-pig ileum.
    Coupar JM; Quinn MJ
    J Pharm Pharmacol; 1988 May; 40(5):378-80. PubMed ID: 2899640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors.
    Shearman GT; Stenfors C
    Pharmacol Biochem Behav; 1986 Apr; 24(4):861-3. PubMed ID: 3012599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bremazocine: a potent, long-acting opiate kappa-agonist.
    Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
    Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of benzomorphan-kappa opiate receptors in cerebral arteries which subserve relaxation.
    Altura BT; Altura BM; Quirion R
    Br J Pharmacol; 1984 Jun; 82(2):459-66. PubMed ID: 6329394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
    Fuller RW; Leander JD
    J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.